Allergan is looking to develop a needle-free formulation of Botox, and it has signed a co-development deal with American Medical Systems to use that company's JetTouch platform.
GE Healthcare will team with the Australian government in its push to develop flutemetamol as a viable PET imaging agent that helps diagnose Alzheimer's disease.
Johnson & Johnson's ($JNJ) Animas will advance a second feasibility study for its artificial pancreas system, after the system generated promising results from first trial effort involving 13 adult patients with Type 1 diabetes.
Electronics giant Panasonic wants to pour in between 30 billion yen ($380 million) and 50 billion yen ($635 million) into the company, according to Bloomberg and a Kyodo News story cited by Reuters .
The emerging biosimilars business takes deep pockets and some major league R&D experience at late-stage studies, which helps explain why Merck KGaA is now partnering with Dr. Reddy's Laboratories on a slate of new antibody programs.
Two major players in Atlanta's academic and healthcare communities are upping their collective investment toward developing new medical devices and treatments specifically for children.
The Juvenile Diabetes Research Foundation is partnering with Medtronic to advance the company's next-generation continuous glucose monitors.
The partnership will have physician scientists from SCRI and Yale Cancer Center working together to develop protocols and priorities for clinical research protocols.
Affymetrix ( $AFFX ) has sealed a deal with Leica Microsystems to create a lab test intended, in part, to help boost development of new companion diagnostic tests.
The New Jersey CRO has teamed up with Bayer Healthcare in a deal that will see the two helping one another with R&D services.